GlassScriptPhysician profile
John Jiuliano
NPI 1871680835
$9,793.11
in general payments reported to CMS, 2019-2025
16 companies · $212 in 2025
The $212 reported for 2025 was less than what a typical Hand Surgery provider received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,544 · 2021: $2,400 · 2022: $2,541 · 2023: $1,651 · 2024: $1,445 · 2025: $212.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,952 · Travel and Lodging: $1,356.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,951.70 |
| Travel and Lodging | $1,356.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pylant Medical | $4,800.00 | 2021-2022 | |
| Trimed, INC. | $1,522.33 | 2023 | |
| Zimmer Biomet Holdings, INC. | $1,389.71 | 2019-2022 | |
| Sonex Health, INC. | $1,109.67 | 2024 | Sx-One Microknife |
| Axogen | $330.05 | 2024-2025 | Axoguard Nerve Connector, Avance Nerve Graft, Axoguard Nerve Protector |
| Stryker Corporation | $223.89 | 2019-2023 | T2 |
| Depuy Synthes Sales INC. | $118.39 | 2023-2025 | Na, Monovisc, Orthovisc |
| Bioventus LLC | $89.36 | 2022-2025 | Exogen Ultrasound Bone Healing System, Durolane |
| Endo Pharmaceuticals INC. | $82.99 | 2019 | |
| Smith+Nephew, INC. | $33.53 | 2024 | Integra, Safeguard, Stravix |
| Ferring Pharmaceuticals INC. | $21.34 | 2023 | Euflexxa |
| Ethicon US, LLC | $19.50 | 2019 | |
| Ossur Americas, INC. | $18.29 | 2025 | |
| Biocircuit Technologies INC | $17.57 | 2025 | Nerve Tape |
| Kerecis Limited | $10.60 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alafair Biosciences, INC. | $5.89 | 2025 | Versawrap |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Jiuliano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.